These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 9378180)

  • 1. [Hepatocellular carcinoma: a preventable cancer].
    Viviani S; Jack A; Bah E; Montesano R
    Epidemiol Prev; 1997; 21(2):129-36. PubMed ID: 9378180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
    Chang MH; You SL; Chen CJ; Liu CJ; Lee CM; Lin SM; Chu HC; Wu TC; Yang SS; Kuo HS; Chen DS;
    J Natl Cancer Inst; 2009 Oct; 101(19):1348-55. PubMed ID: 19759364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems.
    Chang MH; Chen TH; Hsu HM; Wu TC; Kong MS; Liang DC; Ni YH; Chen CJ; Chen DS;
    Clin Cancer Res; 2005 Nov; 11(21):7953-7. PubMed ID: 16278421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
    Sun Z; Zhu Y; Stjernsward J; Hilleman M; Collins R; Zhen Y; Hsia CC; Lu J; Huang F; Ni Z
    Cancer Detect Prev; 1991; 15(4):313-8. PubMed ID: 1665400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gambia Hepatitis Intervention Study. The Gambia Hepatitis Study Group.
    Cancer Res; 1987 Nov; 47(21):5782-7. PubMed ID: 2822233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
    Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
    J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa.
    Kirk GD; Lesi OA; Mendy M; Akano AO; Sam O; Goedert JJ; Hainaut P; Hall AJ; Whittle H; Montesano R
    Hepatology; 2004 Jan; 39(1):211-9. PubMed ID: 14752840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B vaccination: an important method of preventing HBV-related hepatocellular carcinoma.
    Zanetti A
    Ital J Gastroenterol; 1992 Feb; 24(2):100-2. PubMed ID: 1315589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus vaccine in The Gambia, West Africa: synergy between public health research and practice.
    Ryder RW
    Mt Sinai J Med; 1992 Nov; 59(6):487-92. PubMed ID: 1336128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
    Li RC; Yang JY; Gong J; Li YP; Huang ZN; Fang KX; Xu ZY; Liu CB; Zhao K; Zhuang H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 May; 25(5):385-7. PubMed ID: 15231157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus and the control of hepatocellular carcinoma.
    Blumberg BS
    IARC Sci Publ; 1984; (63):243-61. PubMed ID: 6100273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa.
    Kirk GD; Bah E; Montesano R
    Carcinogenesis; 2006 Oct; 27(10):2070-82. PubMed ID: 16679307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B immunization and hepatocellular carcinoma: The Gambia Hepatitis Intervention Study.
    Montesano R
    J Med Virol; 2002 Jul; 67(3):444-6. PubMed ID: 12116042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of malignant liver tumors].
    Rodella S; Picoco C
    Ann Ist Super Sanita; 1996; 32(4):595-610. PubMed ID: 9382428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
    Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
    Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.